Tissue inhibitor of metalloproteinases-1 in breast cancer.
about
High expression of TIMP-1 in human breast cancer tissues is a predictive of resistance to paclitaxel-based chemotherapy.TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesisRapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1.Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitorsStudy of matrix metalloproteinases and their inhibitors in prostate cancer.TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.Far beyond the usual biomarkers in breast cancer: a review.Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.TIMP-1 deficiency subverts cell-cycle dynamics in murine long-term HSCs.Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury.TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2.A microfluidic device for label-free, physical capture of circulating tumor cell clusters.Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell linePrognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer.RA-XII inhibits tumour growth and metastasis in breast tumour-bearing mice via reducing cell adhesion and invasion and promoting matrix degradation.Study of matrix metalloproteinases and their inhibitors in breast cancer.Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancerPlasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection.TIMP-1 as a tumor marker in breast cancer--an update.Using a cell line breast cancer progression system to identify biomarker candidates.MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factorsSTAT3 Target Genes Relevant to Human Cancers.Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue.Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.Down-regulation of TIMP-1 inhibits cell migration, invasion, and metastatic colonization in lung adenocarcinoma.Identification of miR-1293 potential target gene: TIMP-1.Construction of eukaryotic plasmid expressing human TGFBI and its influence on human corneal epithelial cells.Inflammation and cancer.Immunohistochemical expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in invasive breast carcinomaComparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.Human Tissue Inhibitor of Metalloproteinases-1 Improved Wound Healing in Diabetes through Its Anti-apoptotic Effect.Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
P2860
Q27851775-D08ECEEE-4C4F-4A0D-9163-19CBC8239146Q27852459-044B4556-EDD1-4D8F-AF24-04122A30F595Q28743545-DF6F915C-D21F-48B1-8BAD-A466003D9809Q33268341-58F0377B-EC6F-4916-AFB2-E99961B99B6DQ33326151-957A7A10-0A73-430B-8F41-92110CE2925AQ33338236-99123665-A34F-4DD5-A18B-B7E98F69D410Q33708162-09A0CD81-22A2-465B-8FA2-8F2D955EC080Q33880656-B7592049-5E58-4852-AB26-EDFBD0FDFDC4Q33894643-1A9AF24E-7102-4EFF-B9E1-8732C99298A4Q33935217-C483F0D0-08D2-47CB-9BAC-86C3FAF0836FQ34473935-52AA32E2-73CB-4C63-93D0-F9C29FF4EAC3Q35067597-E7AC3A03-4E10-4825-83FD-681758DE1B9EQ35750203-0DF403A8-BF51-4A40-96B6-1F325447EF74Q35772248-D22A6EBC-F5E4-4D45-AC74-35090F6179BCQ35812039-3B525FB6-2665-4C39-A5F3-5031C0FF4003Q36112190-48E90DF3-4FB6-403D-8BC8-AA070C4FA1B1Q36231009-513BB1B3-E82C-40FF-AC1E-45869EF7C786Q36305387-45AD06CF-D59C-42BF-95F5-9BAA4B0FFC9CQ36610142-C835D77D-1809-41FA-A7AC-BF2919F00F8BQ36631494-D06289B0-3EE0-4494-9CAD-815F728C079FQ36661278-DE5B60C6-2F11-40CE-B5DD-6144C36201D8Q36678647-71846631-8CA1-4424-B322-67B5C503AF12Q37068854-17C6A14B-CB45-45EA-BABD-8A5C0B4A4668Q37157590-CEC960D4-3971-4ABC-9E23-91F833809D8FQ37577041-289FF079-41EA-4FCB-AD88-681CBA82302FQ37600292-69E7173D-6C4A-4C9E-A7F4-158BD23683E4Q38205362-049EF99D-9D31-4D75-BBA4-20B2F5E84964Q38323707-689BA58A-E24E-4994-990B-609552473127Q38357653-FD34078A-2770-4621-91E9-AD16EEB60587Q38921163-8B7CF9AC-62E7-4087-B7F5-A8DD644079B2Q39110512-6821663B-582C-4F6F-99B1-22D022F01312Q41826864-579C77F4-9B6A-4E58-A5CB-6B369AA0B5B2Q41853728-4A0623EF-2AF1-43A5-BBE8-CDE803C8EEB0Q42375660-0E0133DC-36DE-484B-A169-BD5EA16CC0E4Q44131334-1208A1F2-2992-4C75-A7F8-ACA329E5E80AQ45871696-32277F90-C4AE-438A-BAF5-226E66F6751FQ46150179-F09199A0-66D4-4628-A729-4B296C0995A4Q47925738-1CB6ECAD-CD47-49AB-92D3-8F78A5203DC3Q54357444-C7B21CED-54C5-48BA-8B45-D23FF7135668Q54777883-87CA53FE-440C-444E-9B72-21BE36845C9C
P2860
Tissue inhibitor of metalloproteinases-1 in breast cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@ast
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@en
type
label
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@ast
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@en
prefLabel
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@ast
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@en
P2093
P356
P1476
Tissue inhibitor of metalloproteinases-1 in breast cancer.
@en
P2093
A-S Schrohl
H Mouridsen
I J Christensen
N Møller Sørensen
U Lademann
P304
P356
10.1677/ERC.1.00719
P577
2005-06-01T00:00:00Z